findmyKOL

Michael Guma, DO

Basic profile

New York Medical College

ORCIDNone on fileNPI
RegionClifton, NJ · NortheastSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Michael Guma is a Rheumatology/Immunology physician affiliated with New York Medical College. OpenAlex indexes 15 publications with 256 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
15publications

Distinct works indexed by OpenAlex.

256citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
28companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1 Metro Blvd
Clifton, NJ 070140010

Telephone

973-230-6610

Provider last certified this registry record 26 May 2026.

View the NPPES registry record

Industry payments

28 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    56%
    Selective T Cell Costimulation Modulator47.2%
    Abatacept99%Orencia1%
    Part D + Part B<11 patients
    Folate Analog Metabolic Inhibitor3.4%
    Methotrexate100%
    Part D121 patients

    + 7 more classes in this area

  • Musculoskeletal

    17%
    RANK Ligand Inhibitor15.9%
    Denosumab99%Prolia1%
    Part D + Part B19 patients
    Nonsteroidal Anti-inflammatory Drug0.7%
    Diclofenac Sodium100%
    Part D38 patients

    + 2 more classes in this area

  • Dermatology

    12.6%
    Corticosteroid12.6%
    Methylprednisolone acetate100%
    Part B, office-administered28 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”